NCT06926868 · Interventional trial
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Overall registry status Recruiting
Phase 2 · Phase 3
Conditions Breast Neoplasms
Delaware Valley sites
- Local Institution - 0310 · Philadelphia, PA · Philadelphia County · Completed
First posted
Registry updated
Added to the directory